Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-049166)

Filing Details

Accession Number:: 0001209191-20-049166
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-02 16:47:11
Reporting Period:: 2020-08-31

Accepted Time:: 2020-09-02 16:47:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1679082	Myovant Sciences Ltd.	MYOV	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1712069	Matthew Lang	C/O Myovant Sciences Inc. 2000 Sierra Point Parkway, 9Th Floor Brisbane CA 94005	General Counsel & Corp. Secy.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-08-31	26,700	$7.78	172,565	No	4	M	Direct
Common Shares	Disposition	2020-08-31	26,700	$20.05	145,865	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Stock Option (Right to Buy)	Disposition	2020-08-31	26,700	$0.00	26,700	$7.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
280,000		2027-07-16	No	4	M	Direct

Footnotes

Shares sold pursuant to a 10b5-1 trading plan.
The shares were sold at prices ranging from $20.00 to $20.415. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.